Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3223]

$Inhibition of HDAC and mTOR may improve outcomes for relapsed/refractory Hodgkin lymphoma$

Inhibition of HDAC and mTOR may improve outcomes for relapsed/refractory Hodgkin lymphoma

VAV1 gene mutations trigger T-cell tumours in mice

VAV1 gene mutations trigger T-cell tumours in mice

Therapy using immune system cells preserves vision in mice implanted with rare eye cancer

Therapy using immune system cells preserves vision in mice implanted with rare eye cancer

The CNIO reprograms CRISPR system in mice to eliminate tumour cells without affecting healthy cells

The CNIO reprograms CRISPR system in mice to eliminate tumour cells without affecting healthy cells

Results of preclinical study demonstrates lilotomab satetraxetan reverses tumour resistance to rituximab in NHL disease models

Results of preclinical study demonstrates lilotomab satetraxetan reverses tumour resistance to rituximab in NHL...

Many Non-Hodgkin's Lymphoma patients can skip radiation, collaborative study finds

Many Non-Hodgkin's Lymphoma patients can skip radiation, collaborative study finds

Temple researchers discover drug resistance mechanism in leukemia, ID treatment strategy

Temple researchers discover drug resistance mechanism in leukemia, ID treatment strategy

Researchers discover drug resistance mechanism in leukaemia, ID treatment strategy

Researchers discover drug resistance mechanism in leukaemia, ID treatment strategy

FDA grants Fast Track designation to Calibr's 'switchable' CAR-T cell cancer therapy

FDA grants Fast Track designation to Calibr's 'switchable' CAR-T cell cancer therapy

An area of the brain where tumour cells shelter from chemotherapy in childhood leukaemia

An area of the brain where tumour cells shelter from chemotherapy in childhood leukaemia

More from ecancer